Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
MYOS > SEC Filings for MYOS > Form 8-K on 29-Jun-2016All Recent SEC Filings

Show all filings for MYOS RENS TECHNOLOGY INC.



Change in Directors or Principal Officers

Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Resignation of Certain Officers

On June 24, 2016, Joseph C. DosSantos, the Chief Financial Officer of MYOS Corporation (the "Company"), informed the Company of his intention to resign his employment with the Company, effective as of June 30, 2016.

Appointment of Certain Officers

On June 28, 2016, the Company entered into an offer letter (the "Offer Letter") with William Waller, age 61, pursuant to which Mr. Waller will serve as the Company's interim Chief Financial Officer. Pursuant to the terms of the Offer Letter, Mr. Waller will work for the Company for an initial 90-day period, and will be compensated at a rate of $125.00 per hour. We currently intend to enter into an agreement with Mr. Waller regarding full-time employment following such 90-day period.

Mr. Waller is an accomplished finance and accounting executive with over thirty years of senior-level experience in building and managing global finance teams, including over a decade in the pharmaceutical industry. From August 2004 to February 2016, Mr. Waller served as Executive Director, Finance at Celgene Cellular Therapeutics, a division of the Celgene Corporation (NASDAQ:CELG), a global biopharmaceutical company. From 1985 to 2004, Mr. Waller held various positions, most recently Vice President and Assistant Treasurer, at Hearst Entertainment and Syndication, a division of the Hearst Corporation, a privately held multi-communication conglomerate. Mr. Waller is a graduate of City University of New York, where he received a B.S. in Accountancy.

There are no family relationships between Mr. Waller and any of the Company's directors or executive officers and the Company has not entered into any transactions with Mr. Waller that are reportable pursuant to Item 404(a) of Regulation S-K.

  Add MYOS to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for MYOS - All Recent SEC Filings
Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.